#USA #New York #Nitra #AI-Health #Healthcare-Tech

Nitra Secures $187 Million to Transform Healthcare with AI

Nitra, recognized as a leading AI-native operating platform specifically architected for healthcare practices, has successfully raised $187 million in its recent funding rounds. This financing, which comprises both Series A and Series B contributions, alongside venture debt and warehouse facility funding, elevates the company's total capital garnered to $205 million, comprising $90 million in equity.

This announcement comes on the heels of a landmark year, wherein Nitra witnessed a staggering growth of over 740% in 2025. The company also celebrated surpassing a remarkable $1 billion in annualized processing volume, a clear indication of the healthcare community’s increasing reliance on advanced AI technologies beyond mere clinical support. These initiatives encompass various aspects of healthcare operations including administration, finances, inventory management, and overall back-office functionalities.

Major Players and Funding Details

The recent funding infusion includes $72 million in fresh equity secured through a $50 million Series B round, complemented by an undisclosed $22 million Series A that had been finalized in August 2025. Key investors involved in this funding round are notable names like Actions Capital, AppWorks, Dunamu Partners, New Enterprise Associates (NEA), Pantera Capital, and Sazze Partners, showcasing a broad spectrum of confidence in Nitra’s platform. Furthermore, the financing was also buoyed by venture debt contributions amounting to $20 million from Avenue Capital Group and a widened warehouse facility of $95 million from Treville Capital Group and Encina Lender Finance, LLC.

Notably, Dr. Richard Park, former CEO of CityMD, has joined Nitra’s Board of Directors, enhancing the leadership team with extensive operational expertise in healthcare as Nitra aims to scale its impactful platform. Under Dr. Park's guidance, CityMD merged with Summit Health, culminating in an acquisition by VillageMD valued at $8.9 billion, creating robust infrastructure within the healthcare vertical.

Addressing the Administrative Burden

Healthcare expenditures in the U.S. hit nearly $5.9 trillion, which places immense pressure on medical practices where up to 25% is often drained by administrative overheads. Many practices still grapple with disjointed systems managing payments, inventory, scheduling, and insurance verifications. Nitra introduced its AI-native operating system, designed to integrate these disparate functionalities seamlessly. This platform empowers healthcare providers, allowing them to regain control over back office processes while funneling manpower back into clinical care instead of administrative tasks.

Launched by visionary leaders Tim Hwang (CEO) and Jonathan Chen (President), the Nitra platform has rapidly evolved to encompass multiple operational niches:

• - Financial Automation: Nitra offers a Visa-backed expense card alongside tools for expense management, bill payments, and automated patient payment processing bolstered by AI for healthcare accounting.
• - Commerce and Inventory: The platform provides access to a vast selection of biopharmaceuticals and medical supplies through partnerships with prominent firms like McKesson and Medline. Nitra’s AI-driven procurement agents adeptly manage supplier relationships, negotiate pricing, execute purchasing tasks, and oversee inventory comprehensively.
• - Patient Management: Unveiled in March 2026, this functional contribution introduces voice AI agents, allowing for enhanced patient scheduling and benefits verification while seamlessly integrating communications with other operational workflows. This aims to significantly minimize the administrative burden that healthcare practices face.

During 2025, Nitra escalated its revenues exponentially from $4 million to beyond $33 million within a single year. The platform is currently utilized by thousands of medical professionals across 700 clinics, demonstrating its capability in processing significant transaction volumes, including a noteworthy throughput of $9 million in high-stakes biopharma transactions in a single day recorded last December.

As Nitra sets sights on expanding its impact further, the objective is to reach beyond 3,000 clinics, achieve over $150 million in annualized revenues, and surpass $4 billion in annual processing volumes by 2026. Additionally, Nitra anticipates its workforce will swell from 50 to over 200 employees by year's end, facilitating the launch of new AI modules focusing on revenue cycle management, patient marketing, and payroll systems.

“We’re on a mission to empower those who serve our communities. By alleviating administrative burdens, we are enabling providers to focus more on patient care,” stated Tim Hwang. He further asserts that Nitra's unified platform is pivotal to merging fragmented workflows into an all-encompassing AI-native operating system, designed from the ground up for healthcare practices.

Nitra has garnered the trust of several distinguished healthcare organizations including Bay Area Retina Associates, Southern Vitreoretinal Associates, and Elase Medspa, to name a few. “Nitra is carving a new niche in healthcare platforms,” remarked Adarsh Bhatt, General Partner at Comma Capital. “The fintech dimension was just the beginning. We recognized the expansive potential with the AI-native infrastructure they are building for healthcare providers. The demand for an advanced operational framework tailored to meet the everyday needs of practices is ever-growing.”

With robust backing and a clear trajectory, Nitra is strategically positioned to revolutionize how healthcare practices manage their operations, leveraging AI to foster efficiency and better healthcare delivery moving forward.